As of May 18
| -0.71 / -1.67%|
The 4 analysts offering 12-month price forecasts for Assembly Biosciences Inc have a median target of 62.50, with a high estimate of 75.00 and a low estimate of 42.00. The median estimate represents a +49.45% increase from the last price of 41.82.
The current consensus among 5 polled investment analysts is to Buy stock in Assembly Biosciences Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.